Tue Feb 14, 2023 – 8:16 pm EST
GAITHERSBURG, Maryland (LifeSiteNews) – Novavax announced a new deal with the U.S. government on Monday in which the company would sell another 1.5 million doses of its abortion-tainted COVID jabs.
The deal, made with the Department of Health and Human Services (HHS), would modify a preexisting contract between Novavax and the government. The deal would also allow for Novavax to support development of smaller jab doses, select strains for testing according to Food and Drug Administration (FDA) recommendations, and allow for a “smoother transition to the commercial market.”
While Novavax did not disclose financial details of the deal, a source familiar with it told The Hill that no new funding was used to support it.
Novavax CEO John Jacobs, speaking about the deal, said in a statement, “This agreement acknowledges the need to offer the American people a diverse COVID-19 vaccine portfolio and underscores the importance of Novavax’s partnership with the U.S. government to ensure continuous access to a protein-based option as part of public health measures.”
The Novavax jab differs from the mRNA injections of both Pfizer and Moderna. It is protein-based and made using an invertebrate cell line
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
